Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Receptor for the C-X-C chemokine CXCL16. Additionally we are shipping CXCR6 Kits (6) and CXCR6 Proteins (5) and many more products for this protein.
Showing 10 out of 227 products:
Chimpanzee Polyclonal CXCR6 Primary Antibody for EIA, IHC (fro) - ABIN492894
Tran, Miller: Chemokine receptors: signposts to brain development and disease. in Nature reviews. Neuroscience 2003
Show all 3 references for ABIN492894
Human Polyclonal CXCR6 Primary Antibody for WB - ABIN126328
Liao, Alkhatib, Peden, Sharma, Berger, Farber: STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. in The Journal of experimental medicine 1997
Dog (Canine) Polyclonal CXCR6 Primary Antibody for EIA, WB - ABIN615957
Lin, Sun, Hu, Wan, Zhao, Yuan, Zhang: Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia. in Cancer letters 2009
Human Polyclonal CXCR6 Primary Antibody for WB - ABIN2792195
Hu, Zhen, Xiong, Wang, Zhang, Zhou: CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. in Cancer science 2008
Human Polyclonal CXCR6 Primary Antibody for EIA, WB - ABIN499485
Deng, Unutmaz, KewalRamani, Littman: Expression cloning of new receptors used by simian and human immunodeficiency viruses. in Nature 1997
High CXCR6 expression is associated with prostate cancer.
MiR (show MLXIP Antibodies)-361-5p was down-regulated in Hepatocellular Carcinoma tissues in comparison to adjacent normal tissues, due to hypermethylation at its promoter region. Overexpression of miR (show MLXIP Antibodies)-361-5p suppressed proliferation and invasion of HCC (show FAM126A Antibodies) cells. Chemokine (C-X-C Motif) receptor 6 (CXCR6) was identified as a target of miR (show MLXIP Antibodies)-361-5p.
Wnt5a (show WNT5A Antibodies)-Ror2 (show ROR2 Antibodies) signaling enhances expression and secretion of CXCL16 (show CXCL16 Antibodies) in mesenchymal stem cells thereby activating CXCR6 expressed on tumor cells to promote proliferation.
high protein expression of CXCL16 (show CXCL16 Antibodies) and high protein co-expression of CXCL16 (show CXCL16 Antibodies)/CXCR6 in prostate cancer were independent predictors for a worse clinical outcome
Authors present evidence that chemokine receptor CXCR6 and its only natural ligand, CXCL16 (show CXCL16 Antibodies), are significantly expressed by non-small cell lung cancer (NSCLC) and are involved in the pathobiology of lung cancer.
we examined the expression of CXCL16 (show CXCL16 Antibodies) and CXCR6 and their relations to prognosis in 335 unselected patients with NSCLC, and investigated possible relationships with our previously studied immunologic and angiogenic markers
high expression of CXCR6 is positively associated with distant invasion of human hepatocellular carcinoma (HCC (show FAM126A Antibodies)) patients.
CXCL16 (show CXCL16 Antibodies)/CXCR6 interaction may play an important role in modifying the response of pDCs to environmental danger signals
Our results suggest that the CXCL16 (show CXCL16 Antibodies)/CXCR6 axis appears to be important in the progression of Ewing sarcoma family tumor
Data suggest that expression of CXCR6 in T-cells and natural killer cells is up-regulated in subjects with metabolic syndrome and correlates with severity of carotid atherosclerosis (i.e., intima-media thickness and plaque index).
CXCR6 has a role in the circulation of innate lymphoid cell precursors and their progeny
CXCR6 is essential for pressure overload-mediated myocardial recruitment of monocytes, which contributes to cardiac fibrosis through TNF-alpha (show TNF Antibodies)-dependent MMP9 (show MMP9 Antibodies) activation and collagen synthesis.
CXCR6 appears to influence long-term survival and tissue distribution of activated T cells.
CXCR6 deficiency inhibited total collagen deposition and suppressed the expression of collagen I and fibronectin (show FN1 Antibodies) in obstructed kidneys.
Intestinal ILC3s expressed CXCR6 and its ablation generated a selective loss of the NKp46 (show NCR1 Antibodies)(+) ILC3 subset, a depletion of intestinal IL-22 (show IL22 Antibodies), and the inability to control C. rodentium infection.
CXCR6 plays important roles in the pathogenesis of arthritis through its effects on both T cell cytokine polarization and homing of T cells to inflamed joints.
critical for the development and maintenance of protective memory CD8 (show CD8A Antibodies)+ T cells in the liver
CXCR6 plays a pivotal role in the development of Ang II (show AGT Antibodies)-induced renal injury and fibrosis through regulation of macrophage and T-cell infiltration and bone marrow-derived fibroblast accumulation.
CXCR6, the receptor for CXCL16 (show CXCL16 Antibodies), is critically involved in the pathogenesis of myocardial remodeling and development of heart failure following ischemia/reperfusion injury.
results demonstrate hepatic NKT (show CTSL1 Antibodies) cells accumulate CXCR6-dependent early upon injury, thereby accentuating the inflammatory response in the liver and promoting hepatic fibrogenesis.
Receptor for the C-X-C chemokine CXCL16. Used as a coreceptor by SIVs and by strains of HIV-2 and m-tropic HIV-1.
C-X-C chemokine receptor type 6
, chemokine C-X-C motif receptor 6
, G protein-coupled receptor TYMSTR
, chemokine (C-X-C motif) receptor 6
, G protein-coupled receptor
, G-protein coupled receptor STRL33
, G-protein coupled receptor bonzo
, chemokine receptor CXCR6
, G protein-coupled receptor STRL33
, chemokine receptor bonzo